Immediate Impact
1 from Science/Nature 70 standout
Citing Papers
Medications for Obesity
2024 Standout
Transforming obesity: The advancement of multi-receptor drugs
2024 Standout
Works of Mary Parks being referenced
Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mary Parks | 60 | 25 | 165 | 246 | 138 | 6 | 568 | |
| Etsuko Shinohara | 102 | 12 | 109 | 107 | 220 | 9 | 514 | |
| Wolfram Woltersdorf | 36 | 31 | 145 | 210 | 113 | 10 | 593 | |
| Zhong‐ning Zhu | 39 | 11 | 83 | 106 | 40 | 14 | 510 | |
| Patrick Imfeld | 67 | 7 | 64 | 130 | 265 | 8 | 644 | |
| Mingxia Zhao | 41 | 6 | 121 | 55 | 66 | 12 | 501 | |
| Eliane Rossini | 116 | 7 | 54 | 214 | 324 | 9 | 602 | |
| Salomon Banarer | 26 | 168 | 291 | 562 | 71 | 7 | 647 | |
| S. I. McFarlane | 51 | 18 | 166 | 118 | 76 | 11 | 464 | |
| Kenji Wakai | 20 | 83 | 65 | 79 | 57 | 8 | 574 | |
| Mayerly Nava | 40 | 8 | 35 | 146 | 110 | 8 | 630 |
All Works
Loading papers...